Skip to main content
. 2020 Sep 14;117(39):24427–24433. doi: 10.1073/pnas.2000060117

Fig. 4.

Fig. 4.

PIK3CA-Ct mutations occur across human cancers and co-occur with actionable genomic alterations. (A) Identity and frequency of PIK3CA-Ct mutations in solid human tumors for alterations, n > 1. (B) Prevalence of PIK3CA-Ct mutations across tumor types. (C) Frequency of additional PI3K pathway alterations in breast cancer. (D) Co-occurring genomic alterations in breast cancer.